胆道内支架置入术治疗恶性梗阻性黄疸的疗效分析

目的 探讨经皮肝胆道内支架置入治疗恶性梗阻性黄疸的疗效及并发症。方法 对32例恶性梗阻性黄疸患者经皮肝穿胆道内行支架置入术，其中28例为内涵管，4例为金属内支架。随访35－376天，观察近中期疗效和并发症。结果 经皮肝胆道内支架置入术技术成功率为100％，置入术后1周血总胆红素水平较置入前明显下降（P＜0.001)。开通时间平均为101天，半年开通率为56.25%，并发症发生率24.98%，为主要包括胰腺炎和逆行胆道感染等。结论 经皮肝胆管内架置入术疗效可靠，是一种安全，可作为恶性胆管阻塞介入治疗的一种姑息性疗法。

Therapeutic Effect Treatment on Malignant Obstructive Jaundice with Percutaneous Transhepatic Stent Implantation

Purpose To investigate the effect and complication of percutaneous transhepatic stent implantation. Methods Percutaneous transhepatic stent implantation was performed in 32 patients with malignant obstructive jaundice: plastic stent of 28 patients, metal stent of 4 patients. The early and late theraputic effects and complications of 32 patients were observed in 35-376 days follow up periods. Results Technical success rate was 100%. Serum total bilirubin decreased significantly after percutaneous transhepatic stent implantation in the first week ( P <0.001). The mean patency time was 101 days,the ratio of half-year patency was 56.25%.The complications occurred in 24.98% of patients,mainly included pancreatitis and retrograde biliary infection. Conclusion Percutaneous transhepatic stent implantation is effective and safe, it can be used as a choice of interventional treatment to malignant biliary obstruction.